FOLFOX Induced Takotsubo Cardiomyopathy Treated with Impella Assist Device.
Swethika SundaravelAbdulah AlrifaiMohamad KabachWaqas GhummanPublished in: Case reports in cardiology (2017)
Chemotherapy induced cardiotoxicity is becoming increasingly prevalent with several new agents being used recently. The incidence of Takotsubo cardiomyopathy due to 5-fluorouracil based chemotherapeutic regimens like FOLFOX is not uncommon. It is also seen with platinum based chemotherapy. Most of these patients have reversible cardiotoxicity and the cardiac function recovers within a short period with supportive treatment. Here we have a patient who presented with cardiogenic shock after 5 days of receiving FOLFOX regimen for colorectal adenocarcinoma. She was treated with a percutaneous left ventricular assist device, Impella CP, for hemodynamic support with excellent outcome.
Keyphrases
- left ventricular assist device
- chemotherapy induced
- newly diagnosed
- end stage renal disease
- metastatic colorectal cancer
- heart failure
- ejection fraction
- chronic kidney disease
- squamous cell carcinoma
- extracorporeal membrane oxygenation
- locally advanced
- peritoneal dialysis
- case report
- minimally invasive
- diabetic rats
- high glucose
- ultrasound guided
- endothelial cells
- combination therapy
- patient reported outcomes
- atrial fibrillation